|  | |
| Names | |
|---|---|
| Preferred IUPAC name N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | |
| Other names Rafoxanid, raphoxanide | |
| Identifiers | |
| 3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.041.029 | 
| EC Number | 
 | 
| KEGG | |
| MeSH | D011888 | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C19H11Cl2I2NO3 | |
| Molar mass | 626.01 g/mol | 
| Appearance | Slight yellowish-brown injectable solution and white oral solution | 
| In oily solutes | |
| Pharmacology | |
| QP52AG05 (WHO) | |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
| Main hazards | Has low safety index (6 times as normal dose) | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Rafoxanide is a salicylanilide used as an anthelmintic.[1] It is most commonly used in ruminant animals to treat adult liver flukes of the species Fasciola hepatica and Fasciola gigantica.[1]
References
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

